SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-032172
Filing Date
2018-05-10
Accepted
2018-05-10 16:21:16
Documents
49
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-9770_110q.htm 10-Q 578385
2 EX-31.1 a18-9770_1ex31d1.htm EX-31.1 11613
3 EX-31.2 a18-9770_1ex31d2.htm EX-31.2 11608
4 EX-32.1 a18-9770_1ex32d1.htm EX-32.1 8583
  Complete submission text file 0001104659-18-032172.txt   3284104

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT osir-20180331.xml EX-101.INS 797956
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT osir-20180331.xsd EX-101.SCH 27420
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT osir-20180331_cal.xml EX-101.CAL 45887
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT osir-20180331_def.xml EX-101.DEF 61816
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT osir-20180331_lab.xml EX-101.LAB 247339
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT osir-20180331_pre.xml EX-101.PRE 161657
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 18822809
SIC: 2836 Biological Products, (No Diagnostic Substances)